Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Nov 08, 2023

BUY
$62.17 - $97.62 $431,086 - $676,897
6,934 Added 35.6%
26,409 $2.58 Million
Q1 2023

May 15, 2023

BUY
$62.17 - $97.62 $431,086 - $676,897
6,934 Added 35.6%
26,409 $2.58 Million
Q4 2022

Nov 08, 2023

BUY
$60.21 - $77.74 $754,551 - $974,237
12,532 Added 180.5%
19,475 $1.21 Million
Q4 2022

Feb 14, 2023

BUY
$60.21 - $77.74 $754,551 - $974,237
12,532 Added 180.5%
19,475 $1.21 Million
Q3 2022

Nov 08, 2023

SELL
$72.92 - $99.73 $60,450 - $82,676
-829 Reduced 10.67%
6,943 $506,000
Q3 2022

Nov 14, 2022

SELL
$72.92 - $99.73 $60,450 - $82,676
-829 Reduced 10.67%
6,943 $506,000
Q2 2022

Nov 08, 2023

BUY
$84.23 - $147.57 $163,069 - $285,695
1,936 Added 33.17%
7,772 $734,000
Q2 2022

Aug 15, 2022

BUY
$84.23 - $147.57 $163,069 - $285,695
1,936 Added 33.17%
7,772 $735,000
Q1 2022

Nov 08, 2023

BUY
$122.89 - $171.74 $717,186 - $1 Million
5,836 New
5,836 $807,000
Q1 2022

May 16, 2022

BUY
$122.89 - $171.74 $161,108 - $225,151
1,311 Added 28.97%
5,836 $807,000
Q3 2021

Nov 08, 2023

BUY
$228.69 - $274.2 $254,531 - $305,184
1,113 Added 32.62%
4,525 $1.17 Million
Q3 2021

Nov 15, 2021

BUY
$228.69 - $274.2 $254,531 - $305,184
1,113 Added 32.62%
4,525 $1.17 Million
Q2 2021

Nov 08, 2023

SELL
$169.89 - $231.37 $1.3 Million - $1.76 Million
-7,628 Reduced 69.09%
3,412 $783,000
Q2 2021

Aug 16, 2021

SELL
$169.89 - $231.37 $1.3 Million - $1.76 Million
-7,628 Reduced 69.09%
3,412 $784,000
Q1 2021

Nov 08, 2023

SELL
$143.93 - $207.3 $9.37 Million - $13.5 Million
-65,126 Reduced 85.51%
11,040 $1.86 Million
Q1 2021

May 13, 2021

SELL
$143.93 - $207.3 $9.37 Million - $13.5 Million
-65,126 Reduced 85.51%
11,040 $1.86 Million
Q4 2020

Nov 08, 2023

BUY
$96.1 - $151.18 $7.32 Million - $11.5 Million
76,166 New
76,166 $11.1 Million
Q4 2020

Feb 16, 2021

SELL
$96.1 - $151.18 $7.94 Million - $12.5 Million
-82,606 Reduced 52.03%
76,166 $11.1 Million
Q3 2020

Nov 08, 2023

SELL
$90.16 - $107.61 $11 Million - $13.1 Million
-121,484 Reduced 43.35%
158,772 $15.7 Million
Q3 2020

Nov 13, 2020

SELL
$90.16 - $107.61 $11 Million - $13.1 Million
-121,484 Reduced 43.35%
158,772 $15.7 Million
Q2 2020

Nov 08, 2023

BUY
$52.17 - $95.63 $13.5 Million - $24.8 Million
259,485 Added 1249.27%
280,256 $26.1 Million
Q2 2020

Aug 13, 2020

BUY
$52.17 - $95.63 $13.5 Million - $24.8 Million
259,485 Added 1249.27%
280,256 $26.1 Million
Q4 2019

Nov 08, 2023

SELL
$69.39 - $97.59 $1.39 Million - $1.96 Million
-20,053 Reduced 49.12%
20,771 $1.99 Million
Q4 2019

Feb 13, 2020

SELL
$69.39 - $97.59 $1.39 Million - $1.96 Million
-20,053 Reduced 49.12%
20,771 $1.99 Million
Q3 2019

Nov 08, 2023

BUY
$64.17 - $84.08 $378,603 - $496,072
5,900 Added 16.89%
40,824 $2.89 Million
Q3 2019

Nov 13, 2019

BUY
$64.17 - $84.08 $378,603 - $496,072
5,900 Added 16.89%
40,824 $2.89 Million
Q2 2019

Nov 08, 2023

BUY
$70.1 - $85.17 $1.98 Million - $2.41 Million
28,244 Added 422.81%
34,924 $2.97 Million
Q2 2019

Aug 13, 2019

BUY
$70.1 - $85.17 $1.98 Million - $2.41 Million
28,244 Added 422.81%
34,924 $2.97 Million
Q1 2019

Nov 08, 2023

BUY
$77.0 - $99.34 $514,360 - $663,591
6,680 New
6,680 $568,000
Q1 2019

May 14, 2019

BUY
$77.0 - $99.34 $514,360 - $663,591
6,680 New
6,680 $569,000

Others Institutions Holding HSKA

About HESKA CORP


  • Ticker HSKA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 10,818,900
  • Description
  • Heska Corporation sells veterinary and animal health diagnostic and specialty products for canine and feline healthcare markets in the United States, Canada, Mexico, Australia, France, Germany, Italy, Malaysia, Spain, and Switzerland. The company offers Element DC, Element DCX, Element DC5x veterinary chemistry analyzers for blood chemistry and ...
More about HSKA
Track This Portfolio

Track Eversept Partners, LP Portfolio

Follow Eversept Partners, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eversept Partners, LP, based on Form 13F filings with the SEC.

News

Stay updated on Eversept Partners, LP with notifications on news.